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Abstract- In this work a new electrochemical method will be presented for the determination 
of enalapril in pharmaceutical tablets using unmodified screen printed electrode (SPE). The 
studies were done using amperommetric detection. Enalapril provides well defined, oval-
shape oxidation peak at +1.05 V (vs. Ag/AgCl, 3.0 M KCl) in Britton-Robinson buffer 
solution (BRBS) at pH 5.0. After optimization of the experimental conditions, the influence 
of most common interferent compounds was tested.  Under optimized experimental 
conditions, the signals were linearly proportional to the concentration of enalapril in the range 
from 2.5 to 90 µM with a detection limit of 0.9 µM. Repeatability of ten replicate 
measurements of 5 µM enalapril was estimated to be 1.5%. Proposed method was 
successfully applied for the determination of the total amount of enalapril content in 
pharmaceutical preparations. Nevertheless, proposed method could be beneficial for the quick 
quantifications of enalapril in drugs using unmodified SPE electrode without any further 
treatment.  















Anal. Bioanal. Electrochem., Vol. 9, No. 8, 2017, 1000-1007                                             1001 
 
1. INTRODUCTION  
Enalapril (ENP) is widely used as an antihypertensive drug. Metabolites of enalapril are 
active inhibitors of angiotensin-I converting enzyme (ACE). Enalapril maleate (EM) {1-[N-
[(S)-1-carboxy-3-phenylpropyl]-L-anayl]-L-proline 1-ethyl ester, maleate (1:1)} is an official 
drug in B.P. [1]. EM is used for the treatment of rennin-dependent hypertension [2] arterial 
hypertension [3,4], and congestive cardiac insufficiency [3], alone or in a combination with 
other drugs [5].  It is also a prodrug (an ethylester) which is hydrolyzed to an active 
compound, enalaprilat [6,7]. It is a very powerful drug with minimal side effects [4] at low 
therapeutic doses [8]. Lately, it was found that the use of enalapril decreases the mortality 
and diminishes the frequency of patient hospitalizations. Due to this fact, the development of 
a low-cost, sensitive, selective and simple analytical procedure for quantification of enalapril 
is of dominant importance especially for quality control of drug. Recently, there are some 
techniques that have been used for enalapril determination in biological samples and 
pharmaceutical formulations based on potentiometry [9], spectrophotometry [10-15], high 
performance liquid chromatography (HPLC) [7, 16-19] and colorimetry [20]. HPLC methods 
are widely used due to their selectivity and sensitivity. These techniques suffer from a time-
consuming sample preparation and analysis and high cost of the instrumentation. 
Electroanalytical methods offer high selectivity and sensitivity, simplicity in sample 
preparation and low-cost instrumentations. Therefore, based on these facts they are widely 
used in analysis of biologically active compounds [21-23]. Due to the enalapril’s complex 
structure, the best of our knowledge there is only a few published research artticles dealing 
with electrochemical determination of enalapril based on modified paste electrode [24] and 
mercury electrodes [25,26]. 
The aim of this work was to develop simple, sensitive and selective electroanalytical 
procedure for determination of total enalapril content in pharmaceutical preparation using 
unmodified screen printed electrode with amperometric detection. Influence of most common 
interferent compounds of enalapril were tested and proposed method was successfully 
applied for the enalapril quantification in pharmaceutical formulation.  
 
2. EXPERIMENTAL  
2.1. Apparatus, solvents and reagents 
Water was purified with a cartridge purification system (Milli-Q) with a resistivity of 18 
MΩ cm and was used for preparation of all the solutions used for this work. Enalapril, 
ascorbic acid, uric acid, dopamine, boric acid, sodium hydroxide, acetic acid, maleic acid, 
magnesium stearat, sodium lauryl sulphate and phosphoric acid were purchased from Sigma-
Aldrich (Vienna, Austria) and used as received without any further purification. Calibration 
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supporting electrolyte. Britton-Robinson buffer solution (BRBS) was prepared by mixing of 
phosphoric acid, acetic acid and boric acid (all at 40 mM) adjusting the pH with sodium 
hydroxide (0.2 M) to the desired value.  
Cyclic voltammetric (CV) and amperometric measurements were performed using an 
electrochemical analyzer (PalmSens BV, The Netherlands) controlled by a personal computer 
with the necessary software (PS Trace, version 1.2). 
The electrochemical cell (20 mL) contained a three-electrode system with a screen printed 
working electrode, an Ag/AgCl (3.0 M KCl) reference electrode and a Pt as a counter 
electrode. All working potential values in this work are reported versus Ag/AgCl reference 
electrode at room temperature.  
For the CV measurements, the potential was swept over the range from 0 to +1.4 V (vs. 
Ag/AgCl) at the different scan rates, and for amperometric measurements potential was kept 
constant at +1.05 V (vs. Ag/AgCl). 
 
2.2. Sample preparation  
Tablets containing ENP were weighed and a suitable amount of the powder was 
transferred to 10.0 mL calibrated volumetric flasks containing ethanol. Next, 100 µL of this 
solution was transferred to electrochemical cell with BRBS (pH 5.0). The ENP 
concentrations in each sample were determined using the regression equation of previously 
plotted analytical curves obtained with standard solutions of each analyte. These results were 
finally compared with those proposed by supplier.  
 
3. RESULTS AND DISCUSSIONS  
3.1. Electrochemical behavior of enalapril, effect of pH and scan rate 
Electrochemical behavior of enalapril was studied using cyclic voltammetry and the 
influence on peak current and peak potential was investigated at different pH values of 
Britton-Robinson buffer solution. In acidic media, enalapril provided well-defined 
irreversible oxidation peak at around +1.05 V. Increasing of pH of the supporting electrolyte 
solution effects in a loss of the peak. When increasing the pH value of supporting electrolyte 
from 2.0 to 6.0 the peak potentials shifts to less positive potential and peak current increases 
to the pH value of 5.0. From Figure 1A and 1B can be concluded that most suitable pH of 
supporting electrolyte for oxidation of enalapril is at pH 5.0. Dependence of the peak 
potential from pH (Figure 1C) gives the conclusion that there is no proton participation in the 
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Fig. 1. A) CV voltammograms of enalapril at SPE in BRBS at different pH (2.0-9.0), scan 
rate 100 mV/s. B) CV voltammogram of enalapril at SPE in BRBS at pH 5.0, scan rate of 100 





Scheme 1. Proposed mechanism for electrochemical oxidation of enalapril at SPE in BRBS 
at pH 5.0 
 
 
Fig. 2. CV voltammograms obtained for 0.1 mM of enalapril solution at SPE, at pH 5.0 of 
BRBS at different scan rates (10-100 mV/s). Inset figure present dependence of peak current 
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3.2. Enalapril detection and performance of screen printed electrode 
Amperometric determination of enalapril has been performed over a wide analyte 
concentration range of 2.5-90 µM at previously optimized experimental conditions, detection 
potential and pH of supporting electrolyte solution. Limit of detection and response time were 
estimated from the amperometric response of analyte. Calibration curve was constructed by 
plotting current values and different concentrations of enalapril. Under optimized 
experimental conditions, the signals were linearly proportional to the concentration of 
enalapril in the range from 2.5 to 90 µM (Figure 3A) with a detection limit of 0.9 µM. 
Corresponding regression equation (Figure 3B) was calculated to be 
I(µA)=(0.0146±0.0008) c (µM)+(1.6317±0.0003) with correlation coefficient of 0.9977. 
Proposed method has wide linear range and obtained detection limit is comparable or better 
than those reported in literature using chemically modified electrodes [24-26]. Valezi et al. 
proposed similar detection limit of 0.81 µM but lower linear range from 2 to 57 µM [24], 
Gusakova and Ivanovskaya proposed wider linear range with similar LOD using mercury 
film electrode [25], while Elmali et al. proposed higher LOD and lower linear range from 40-
100 µM using differential pulse polarography at static mercury dropping electrode [26]. 
However, mercury itself has been recently considered as poisonous and toxic substance and 
due to that our developed method can be satisfactory procedure for fast, environmentally 
friendly and reliable detection of ENP.  
 
 
Fig. 3. A) Amperometric response obtained by proposed sensor under optimized 
experimental conditions, at potential of +1.05 V. B) Calibration curve for amperometric 
response of proposed electrode 
 
3.3. Influence of most common interferences 
Perhaps most important advantages of one analytical methodology are based on the 
selectivity. Influence of most common interferents of enalapril in pharmaceutical 
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of SPE for determination of analyte was analyzed or tested in presence of magnesium stearate 
(MS), sodium lauryl sulphate (SLS) and maleic acid (MA). It was found that tested 
compounds do not have significant influence on obtained current responses for enalapril in 
10-fold excess (Figure 4A). In presence of ascorbic acid (AA), uric acid (UA) and dopamine 
(DOP) there are significantly changes in current by adding same amount of tested compound 
which indicated that proposed analytical procedure is not suitable for determination of 
enalapril in human samples (Figure 4B). 
 
 
Fig. 4. A) Amperometric response of proposed electrode for determination of enalapril in 
presence of MA, SLS and MS as an interferent compounds. B) Amperometric response of 
SCE for enalapril in presence of AA, DOP and UA. All measurements were carried out under 
optimized parameters at potential of +1.05 V  
 
 
Fig. 5. Amperometric response obtained for the determination of enalapril in tablets under 









Anal. Bioanal. Electrochem., Vol. 9, No. 8, 2017, 1000-1007                                             1006 
 
3.4. Analytical application  
In order to investigate applicability of the proposed analytical methodology and accuracy 
of recovery measurements, SPE was applied for the determination of total enalapril content in 
pharmaceutical tablets using amperometric detection. Tablets are prepared as previously 
described. Figure 5 shows the current peaks recorded by addition of the solution of enalapril 
obtained from the pharmaceutical tablets and duplicate additions of the enalapril standard 
solution. Results are obtained from calibration curve (Table 1) and compared with those 
proposed by supplier. It can be concluded that these obtained results for quantification of 
enalapril are in a good agreement with those proposed by supplier and recovery was in the 
range of 98-104 % which indicates the efficacy of the proposed sensor for practical analysis.  
 
Table 1. Results obtained for the determination of enalapril and recovery experiments 
 











Tablet 1 10.01 10.00 5.00/5.00 14.71/20.41 98/102 
Tablet 2 10.15 10.00 5.00/5.00 15.31/20.96 101/104 
  
4. CONCLUSION  
In this work we have demonstrated the use of unmodified screen printed electrode as an 
electrochemical sensor for the quick quantification of enalapril in pharmaceuticals using 
amperometric detection. The proposed sensor does not require any complex procedure for the 
construction. The enalapril content was detected with a low detection limit and wide linear 
range. Effect of most common interferent compounds was also investigated and proposed 
method was successfully applied for the determination of enalapril content in pharmaceutical 
tablets with satisfactory recovery. This method offers alternative procedure for the 
determination of enalapril with a high selectivity and sensitivity, low cost instrumentation 
setup and could be replacement for separation methods. 
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